Wahba Ihab M, Mak Robert H
Department of Medicine, Division of Nephrology and Hypertension, Oregon Health & Science University, Portland, Oregon, USA.
Clin J Am Soc Nephrol. 2007 May;2(3):550-62. doi: 10.2215/CJN.04071206. Epub 2007 Mar 14.
There is an epidemic of obesity and the metabolic syndrome in the United States and across the world. Both entities are associated with high mortality, mainly as a result of cardiovascular disease. The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease (CKD). Several recent epidemiologic studies have shown that obesity and the metabolic syndrome are independent predictors of CKD. In addition to diabetes and hypertension, several other mechanisms have been postulated to initiate and maintain kidney injury in patients with obesity and the metabolic syndrome. This article reviews the recent epidemiologic data linking obesity and the metabolic syndrome to CKD and summarizes the potential mechanisms of renal injury in this setting, with a focus on the role of inflammation, lipotoxicity, and hemodynamic factors. Potential preventive and therapeutic modalities based on the limited evidence available are discussed.
在美国乃至全世界,肥胖和代谢综合征正呈流行态势。这两种情况都与高死亡率相关,主要是心血管疾病所致。肥胖的流行伴随着慢性肾脏病(CKD)发病率的上升。最近的几项流行病学研究表明,肥胖和代谢综合征是CKD的独立预测因素。除了糖尿病和高血压外,还提出了其他几种机制来引发和维持肥胖及代谢综合征患者的肾损伤。本文综述了将肥胖和代谢综合征与CKD联系起来的最新流行病学数据,并总结了在这种情况下肾损伤的潜在机制,重点关注炎症、脂毒性和血流动力学因素的作用。基于现有有限证据讨论了潜在的预防和治疗方法。